Consequently, inhibiting phosphoinositide-3-kinases (PI3Ks) (upstream regulators of mTOR) simultaneously with mTOR, successfully prevented T-cell (allo-) activation and GvHD induction (21). This evidence concerns the gene MTOR and graft versus host disease.